The role of adenosine in the regulation of sleep

Current Topics in Medicinal Chemistry

Volumn 11, Issue 8, 2011, Pages 1047-1057

  Huang, Zhi Li ^a,b   Urade, Yoshihiro ^a   Hayaishi, Osamu ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b FUDAN UNIVERSITY   (China)

Author keywords

Adenosine; Knockout mice; Prostaglandin D2; Receptor; Sleep; Wakefulness

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 ANILINOADENOSINE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 6 ETHYL 2 PHENYL 4 PROPYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; 6 N (5 HYDROXYNORBORNAN 2 YL) 8 (N ISOPROPYL N METHYLAMINO) 9 METHYLADENINE; 6 N CYCLOPENTYLADENOSINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE DEAMINASE; ADENOSINE KINASE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; ADENOSYLHOMOCYSTEINASE; CAFFEINE; CYCLIC AMP; CYCLOHEXYLADENOSINE; GUANINE NUCLEOTIDE BINDING PROTEIN; KF 17387; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; NEUROTRANSMITTER; PROSTAGLANDIN D2; UNCLASSIFIED DRUG;

ARTICLE; BRAIN CORTEX; BRAIN REGION; FOREBRAIN; HUMAN; NONHUMAN; SIGNAL TRANSDUCTION; SLEEP; SLEEP DISORDER; SLEEP INDUCTION; SLEEP WAKING CYCLE; SUBARACHNOID SPACE;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; CAFFEINE; EXTRACELLULAR SPACE; GENE EXPRESSION; HUMANS; MICE; MICE, KNOCKOUT; NEURONS; NEUROTRANSMITTER AGENTS; NUCLEOSIDE TRANSPORT PROTEINS; PREOPTIC AREA; PROSTAGLANDIN D2; PURINERGIC P1 RECEPTOR AGONISTS; RATS; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM; SUBARACHNOID SPACE; SYNAPTIC TRANSMISSION; WAKEFULNESS;

EID: 79953234442     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802611795347654     Document Type: Article

References (97)

1. Porkka-Heiskanen, T.; Strecker, R. E.; McCarley, R. W. Brain sitespecificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience, 2000, 99, 507-517.
2. 2A signaling. Prog. Neurobiol., 2007, 83, 263-276.
3. Huang, Z. L.; Urade, Y.; Hayaishi, O. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol., 2007, 7, 33-38.
4. Satoh, S.; Matsumura, H.; Suzuki, F.; Hayaishi, O. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proc. Natl. Acad. Sci. USA, 1996, 93, 5980-5984.
5. 2 and adenosine in sleep regulation: experimental evidence from pharmacological approaches to gene-knockout mice. Future Neurol., 2010, 5, 363-376.
6. Narumiya, S.; Ogorochi, T.; Nakao, K.; Hayaishi, O. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci., 1982, 31, 2093-2103.
7. Ogorochi, T.; Narumiya, S.; Mizuno, N.; Yamashita, K.; Miyazaki, H.; Hayaishi, O. Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. J. Neurochem., 1984, 43, 71-82.
8. Pandey, H. P.; Ram, A.; Matsumura, H.; Hayaishi, O. Concentration of prostaglandin D2 in cerebrospinal fluid exhibits a circadian alteration in conscious rats. Biochem. Mol. Biol. Int., 1995, 37, 431-437.
9. Ram, A.; Pandey, H. P.; Matsumura, H.; Kasahara-Orita, K.; Nakajima, T.; Takahata, R.; Satoh, S.; Terao, A.; Hayaishi, O. CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats. Brain Res., 1997, 751, 81-89.
10. Ueno, R.; Ishikawa, Y.; Nakayama, T.; Hayaishi, O. Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. Biochem. Biophys. Res. Commun., 1982, 109, 576-582.
11. Ueno, R.; Honda, K.; Inoue, S.; Hayaishi, O. Prostaglandin D2, a cerebral sleep-inducing substance in rats. Proc. Natl. Acad. Sci. USA, 1983, 80, 1735-1737.
12. 2, a cerebral sleep-inducing substance in monkeys. Proc. Natl. Acad. Sci. USA, 1988, 85, 4082-4086.
13. Mizoguchi, A.; Eguchi, N.; Kimura, K.; Kiyohara, Y.; Qu, W. M.; Huang, Z. L.; Mochizuki, T.; Lazarus, M.; Kobayashi, T.; Kaneko, T.; Narumiya, S.; Urade, Y.; Hayaishi, O. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. USA, 2001, 98, 11674-11679.
14. Urade, Y.; Kitahama, K.; Ohishi, H.; Kaneko, T.; Mizuno, N.; Hayaishi, O. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc. Natl. Acad. Sci. USA, 1993, 90, 9070-9074.
15. Mohri, I.; Eguchi, N.; Suzuki, K.; Urade, Y.; Taniike, M. Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain. Glia, 2003, 42, 263-274.
16. Jordan, W.; Tumani, H.; Cohrs, S.; Eggert, S.; Rodenbeck, A.; Brunner, E.; Ruther, E.; Hajak, G. Prostaglandin D synthase (betatrace) in healthy human sleep. Sleep, 2004, 27, 867-874.
17. Islam, F.; Watanabe, Y.; Morii, H.; Hayaishi, O. Inhibition of rat brain prostaglandin D synthase by inorganic selenocompounds. Arch. Biochem. Biophys., 1991, 289, 161-166.
18. Matsumura, H.; Takahata, R.; Hayaishi, O. Inhibition of sleep in rats by inorganic selenium compounds, inhibitors of prostaglandin D synthase. Proc. Natl. Acad. Sci. USA, 1991, 88, 9046-9050.
19. Takahata, R.; Matsumura, H.; Kantha, S. S.; Kubo, E.; Kawase, K.; Sakai, T.; Hayaishi, O. Intravenous administration of inorganic selenium compounds, inhibitors of prostaglandin D synthase, inhibits sleep in freely moving rats. Brain Res., 1993, 623, 65-71.
20. Qu, W. M.; Huang, Z. L.; Xu, X. H.; Aritake, K.; Eguchi, N.; Nambu, F.; Narumiya, S.; Urade, Y.; Hayaishi, O. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proc. Natl. Acad. Sci. USA, 2006, 103, 17949-17954.
21. Zimmermann, H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol., 2000, 362, 299-309.
22. Sala-Newby, G. B.; Skladanowski, A. C.; Newby, A. C. The mechanism of adenosine formation in cells. Cloning of cytosolic 5'-nucleotidase-I. J. Biol. Chem., 1999, 274, 17789-17793.
23. Zimmermann, H.; Braun, N.; Kegel, B.; Heine, P. New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem. Int., 1998, 32, 421-425.
24. Brundege, J. M.; Diao, L.; Proctor, W. R.; Dunwiddie, T. V. The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus. Neuropharmacology, 1997, 36, 1201-1210.
25. Rosenberg, P. A.; Li, Y. Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by beta-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex. Brain Res., 1995, 692, 227-232.
26. Dunwiddie, T. V.; Masino, S. A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 2001, 24, 31-55.
27. Deussen, A.; Lloyd, H. G.; Schrader, J. Contribution of Sadenosylhomocysteine to cardiac adenosine formation, J. Mol. Cell Cardiol., 1989, 21, 773-782.
28. Latini, S.; Pedata, F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem., 2001, 79, 463-484.
29. Burnstock, G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev., 2007, 87, 659-797.
30. Gu, J. G.; Foga, I. O.; Parkinson, F. E.; Geiger, J. D. Involvement of bidirectional adenosine transporters in the release of L-[3H]adenosine from rat brain synaptosomal preparations. J. Neurochem., 1995, 64, 2105-2110.
31. Peng, L.; Huang, R.; Yu, A. C.; Fung, K. Y.; Rathbone, M. P.; Hertz, L. Nucleoside transporter expression and function in cultured mouse astrocytes. Glia, 2005, 52, 25-35.
32. Geiger, J. D.; Fyda, D. M. In: Adenosine Transport in Nervous System Tissues. T.W. Stone Ed., Adenosine in the Nervous System, Academic Press: London, 1991.
33. Fredholm, B. B.; Chen, J. F.; Cunha, R. A.; Svenningsson, P.; Vaugeois, J. M. Adenosine and brain function. Int. Rev. Neurobiol., 2005, 63, 191-270.
34. Nagy, J. I.; LaBella, L. A.; Buss, M.; Daddona, P. E. Immunohistochemistry of adenosine deaminase: implications for adenosine neurotransmission. Science, 1984, 224, 166-168.
35. 1 receptors and promotes non-rapid eye movement sleep. Proc. Natl. Acad. Sci. USA, 2008, 105, 19992-19997.
36. Feldberg, W.; Sherwood, S. L. Injections of drugs into the lateral ventricle of the cat. J. Physiol., 1954, 123, 148-167.
37. Basheer, R.; Strecker, R. E.; Thakkar, M. M.; McCarley, R. W. Adenosine and sleep-wake regulation. Prog. Neurobiol., 2004, 73, 379-396.
38. Stenberg, D.; Porkka-Heiskanen, T. Eds. Neurochemistry of Sleep and Wakefulness, Cambridge Univ Press: Cambridge, 2008, pp. 337-362
39. Radek, R. J.; Decker, M. W.; Jarvis, M. F. The adenosine kinase inhibitor ABT-702 augments EEG slow waves in rats. Brain Res., 2004, 1026, 74-83.
40. Okada, T.; Mochizuki, T.; Huang, Z. L.; Eguchi, N.; Sugita, Y.; Urade, Y.; Hayaishi, O. Dominant localization of adenosine deaminase in leptomeninges and involvement of the enzyme in sleep. Biochem. Biophys. Res. Commun., 2003, 312, 29-34.
41. Radulovacki, M.; Virus, R. M.; Djuricic-Nedelson, M.; Green, R. D. Hypnotic effects of deoxycorformycin in rats. Brain Res., 1983, 271, 392-395.
42. Porkka-Heiskanen, T.; Strecker, R. E.; Thakkar, M.; Bjorkum, A. A.; Greene, R. W.; McCarley, R. W. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science, 1997, 276, 1265-1268.
43. Franken, P.; Chollet, D.; Tafti, M. The homeostatic regulation of sleep need is under genetic control. J. Neurosci., 2001, 21, 2610-2621.
44. Retey, J. V.; Adam, M.; Honegger, E.; Khatami, R.; Luhmann, U. F.; Jung, H. H.; Berger, W.; Landolt, H. P. A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc. Natl. Acad. Sci. USA, 2005, 102, 15676-15681.
45. Borbely, A. A.; Achermann, P. Eds., Sleep homeostasis and models of sleep regulation. Elsevier Saunders, Philadelphia, PA, 2005, pp. 405-417
46. Huston, J. P.; Haas, H. L.; Boix, F.; Pfister, M.; Decking, U.; Schrader, J.; Schwarting, R. K. Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats. Neuroscience, 1996, 73, 99-107.
47. Murillo-Rodriguez, E.; Blanco-Centurion, C.; Gerashchenko, D.; Salin-Pascual, R. J.; Shiromani, P. J. The diurnal rhythm of adenosine levels in the basal forebrain of young and old rats. Neuroscience, 2004, 123, 361-370.
48. Strecker, R. E.; Morairty, S.; Thakkar, M. M.; Porkka-Heiskanen, T.; Basheer, R.; Dauphin, L. J.; Rainnie, D. G.; Portas, C. M.; Greene, R. W.; McCarley, R. W. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav. Brain Res., 2000, 115, 183-204.
49. McCarley, R. W. Neurobiology of REM and NREM sleep. Sleep Med., 2007, 8, 302-330.
50. Kalinchuk, A. V.; McCarley, R. W.; Porkka-Heiskanen, T.; Basheer, R. Sleep deprivation triggers inducible nitric oxide synthase-dependent nitric oxide production in wake-active basal forebrain neurons. J. Neurosci., 2010, 30, 13254-13264.
51. Jones, B. E. Glia, adenosine, and sleep. Neuron, 2009, 61, 156-157.
52. Zhang, Z.; Chen, G.; Zhou, W.; Song, A.; Xu, T.; Luo, Q.; Wang, W.; Gu, X. S.; Duan, S. Regulated ATP release from astrocytes through lysosome exocytosis. Nat. Cell Biol., 2007, 9, 945-953.
53. Jourdain, P.; Bergersen, L. H.; Bhaukaurally, K.; Bezzi, P.; Santello, M.; Domercq, M.; Matute, C.; Tonello, F.; Gundersen, V.; Volterra, A. Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci., 2007, 10, 331-339.
54. Pascual, O.; Casper, K. B.; Kubera, C.; Zhang, J.; Revilla-Sanchez, R.; Sul, J. Y.; Takano, H.; Moss, S. J.; McCarthy, K.; Haydon, P. G. Astrocytic purinergic signaling coordinates synaptic networks. Science, 2005, 310, 113-116.
55. Halassa, M. M.; Florian, C.; Fellin, T.; Munoz, J. R.; Lee, S. Y.; Abel, T.; Haydon, P. G.; Frank, M. G. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron, 2009, 61, 213-219.
56. Jacobson, K. A.; Gao, Z. G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov., 2006, 5, 247-264.
57. Yaar, R.; Jones, M. R.; Chen, J. F.; Ravid, K. Animal models for the study of adenosine receptor function. J. Cell Physiol., 2005, 202, 9-20.
58. Fredholm, B. B.; AP, I. J.; Jacobson, K. A.; Klotz, K. N.; Linden, J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 2001, 53, 527-552.
59. 1 and A2a receptor analogs into the lateral preoptic area of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2005, 289, R1715-1723.
60. 2A receptor in sleep promotion. Eur. J. Neurosci., 1998, 351, 155-162.
61. Scammell, T. E.; Gerashchenko, D. Y.; Mochizuki, T.; McCarthy, M. T.; Estabrooke, I. V.; Sears, C. A.; Saper, C. B.; Urade, Y.; Hayaishi, O. An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience, 2001, 107, 653-663.
62. 2A receptor-deficient mice. Neurology, 2003, 61, S94-96.
63. Marks, G. A.; Shaffery, J. P.; Speciale, S. G.; Birabil, C. G. Enhancement of rapid eye movement sleep in the rat by actions at A1 and A2a adenosine receptor subtypes with a differential sensitivity to atropine. Neuroscience, 2003, 116, 913-920.
64. Gerashchenko, D.; Okano, Y.; Urade, Y.; Inoue, S.; Hayaishi, O. Strong rebound of wakefulness follows prostaglandin D2-or adenosine A2a receptor agonist-induced sleep. J. Sleep Res., 2000, 9, 81-87.
65. 2A receptor agonist. Eur. J. Neurosci., 1999, 11, 1587-1597.
66. Sherin, J. E.; Elmquist, J. K.; Torrealba, F.; Saper, C. B. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci., 1998, 18, 4705-4721.
67. 2A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J. Neurochem., 2005, 92, 1542-1549.
68. Saper, C. B.; Scammell, T. E.; Lu, J. Hypothalamic regulation of sleep and circadian rhythms. Nature, 2005, 437, 1257-1263.
69. 2A receptors in the ventrolateral preoptic nucleus. Neuroscience, 2005, 134, 1377-1390.
70. Huang, Z. L.; Qu, W. M.; Eguchi, N.; Chen, J. F.; Schwarzschild, M. A.; Fredholm, B. B.; Urade, Y.; Hayaishi, O. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat. Neurosci., 2005, 8, 858-859.
71. 2A receptor blockade. Neuropharmacology, 2003, 45, 977-985.
72. Missale, C.; Nash, S. R.; Robinson, S. W.; Jaber, M.; Caron, M. G. Dopamine receptors: from structure to function. Physiol. Rev., 1998, 78, 189-225.
73. Qu, W. M.; Xu, X. H.; Yan, M. M.; Wang, Y. Q.; Urade, Y.; Huang, Z. L. Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J. Neurosci., 2010, 30, 4382-4389.
74. Qiu, M. H.; Qu, W. M.; Xu, X. H.; Yan, M. M.; Urade, Y.; Huang, Z. L. D(1)/D(2) receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice. Pharmacol. Biochem. Behav., 2009, 94, 16-23.
75. 2 receptors are essential for the arousal effect of modafinil. J. Neurosci., 2008, 28, 8462-8469.
76. Ferre, S.; Diamond, I.; Goldberg, S. R.; Yao, L.; Hourani, S. M.; Huang, Z. L.; Urade, Y.; Kitchen, I. Adenosine A(2A) receptors in ventral striatum, hypothalamus and nociceptive circuitry Implications for drug addiction, sleep and pain. Prog. Neurobiol., 2007, 83, 332-347.
77. 2A receptors and basal ganglia physiology. Prog. Neurobiol., 2007, 83, 277-292.
78. 1 receptors. Brain Res., 2002, 944, 190-194.
79. Benington, J. H.; Kodali, S. K.; Heller, H. C. Stimulation of A1 adenosine receptors mimics the electroencephalographic effects of sleep deprivation. Brain Res. 1995, 692, 79-85.
80. Schwierin, B.; Borbely, A. A.; Tobler, I. Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur. J. Neurosci., 1996, 300, 163-171.
81. 1 receptor in the cholinergic basal forebrain. J. Neurosci., 2003, 23, 4278-4287.
82. Arrigoni, E.; Chamberlin, N. L.; Saper, C. B.; McCarley, R. W. Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro. Neuroscience, 2006, 140, 403-413.
83. Rainnie, D. G.; Grunze, H. C.; McCarley, R. W.; Greene, R. W. Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science, 1994, 263, 689-692.
84. Christie, M. A.; Bolortuya, Y.; Chen, L. C.; McKenna, J. T.; McCarley, R. W.; Strecker, R. E. Microdialysis elevation of adenosine in the basal forebrain produces vigilance impairments in the rat psychomotor vigilance task. Sleep, 2008, 31, 1393-1398.
85. 1 adenosine receptor binding in the human brain: a positron emission tomography study. J. Neurosci., 2007, 27, 2410-2415.
86. Elmenhorst, D.; Basheer, R.; McCarley, R. W.; Bauer, A. Sleep deprivation increases A(1) adenosine receptor density in the rat brain. Brain Res., 2009, 1258, 53-58.
87. 1 adenosine receptors in the rat basal forebrain. Neuroreport, 2007, 18, 1895-1899.
88. 1 receptor. J. Sleep Res., 2003, 12, 283-290.
89. Blanco-Centurion, C.; Xu, M.; Murillo-Rodriguez, E.; Gerashchenko, D.; Shiromani, A. M.; Salin-Pascual, R. J.; Hof, P. R.; Shiromani, P. J. Adenosine and sleep homeostasis in the Basal forebrain. J. Neurosci., 2006, 26, 8092-8100.
90. Kalinchuk, A. V.; McCarley, R. W.; Stenberg, D.; Porkka-Heiskanen, T.; Basheer, R. The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions. Neuroscience, 2008, 157, 238-253.
91. Noor Alam, M. D.; Szymusiak, R.; McGinty, D. Adenosinergic regulation of sleep: multiple sites of action in the brain. Sleep, 2006, 29, 1384-1385; discussion 1387-1389.
92. Kaur, S.; Junek, A.; Black, M. A.; Semba, K. Effects of ibotenate and 192IgG-saporin lesions of the nucleus basalis magnocellularis/substantia innominata on spontaneous sleep and wake states and on recovery sleep after sleep deprivation in rats. J. Neurosci., 2008, 28, 491-504.
93. Thakkar, M. M.; Engemann, S. C.; Walsh, K. M.; Sahota, P. K. Adenosine and the homeostatic control of sleep: Effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleepwakefulness. Neuroscience, 2008, 153, 875-880.
94. 1 receptor mediated adenosinergic regulation of perifornical-lateral hypothalamic area neurons in freely behaving rats. Neuroscience, 2010, 167, 40-48.
95. 2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin. Pharmacol. Ther., 2007, 81, 692-698.
96. Fredholm, B. B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ., 2007, 14, 1315-1323.
97. Sawynok, J.; Liu, X. J. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog. Neurobiol., 2003, 69, 313-340.